The involvement of Cdk5 activator p35 in social isolation-triggered onset of early alzheimers disease-related cognitive deficit in the transgenic mice

Neuropsychopharmacology

Volumn 36, Issue 9, 2011, Pages 1848-1858

  Hsiao, Ya Hsin ^a   Chen, Po See ^a   Chen, Shun Hua ^a   Gean, Po Wu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer s disease; amyloid ; learning and memory; long term potentiation; peptide; social isolation

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALPAIN; CYCLIN DEPENDENT KINASE 5; PRESENILIN 1; PROTEIN P25; PROTEIN P35;

ALZHEIMER DISEASE; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCYTOSIS; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SOCIAL ISOLATION; TRANSGENIC MOUSE; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; ORGAN CULTURE TECHNIQUES; SOCIAL ISOLATION;

EID: 79960322966     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.69     Document Type: Article

References (50)

1. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR (1997). Regulatory phosphorylation of AMPA-type glutamate receptors by Ca MKII during long-term potentiation. Science 276: 2042-2045. (Pubitemid 27443609)
2. Billings LM, Oddo S, Green KN, Mc Gaugh JL, Laferla FM (2005). Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688. (Pubitemid 40320703)
3. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N et al (2009). The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 14: 95-105.
4. Chan A, Tchantchou F, Rogers EJ, Shea TB (2009). Dietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by Apo E genotype and alleviation by S-adenosyl methionine. J Neurochemistry 110: 831-836.
5. Cruz JC, Tseng H, Goldman JA, Shih H, Tsai LH (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40: 471-483. (Pubitemid 37494698)
6. Davis M (2006). Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61: 741-756. (Pubitemid 44789942)
7. Dewachter I, Filipkowski RK, Priller C, Ris L, Neyton J, Croes S et al (2009). Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neuro-biol Aging 30: 241-256.
8. 2/calmodulin-dependent protein kinase II and a-actinin-1 in a calcium-dependent manner. J Neurosci 22: 7879-7891. (Pubitemid 35379093)
9. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG (2004). Modulation for hippocampal cell proli-feration, memory, and amyloid plaque deposition in APPsw (Tg 2567) mutant mice by isolation stress. Neuroscience 127: 601-609. (Pubitemid 38993164)
10. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP et al (2003). Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100: 4162-4167. (Pubitemid 36418174)
11. Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH (2005). Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48: 825-838. (Pubitemid 41759432)
12. Green KN, Billings LM, Roozendaal B, Mc Gaugh JL, La Ferla FM (2006). Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26: 9047-9056. (Pubitemid 44319396)
13. Gu Z, Liu W, Yan Z (2009). {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution. J Biol Chem 284: 10639-10649.
14. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL et al (1992). Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
15. Hsiao YH, Chen PS, Lin CH, Gean PW (2008). N-acetylcysteine prevents /í-amyloid toxicity by retarding proteolytic degradation of a cyclin-dependent kinase 5 activator in cultured cortical neurons. J Neurosci Res 86: 2685-2695.
16. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S et al (2006). AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52: 831-843. (Pubitemid 44828454)
17. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP et al (2001). Metabolic regulation of brain Abeta by neprilysin. Science 292: 1550-1552. (Pubitemid 32493424)
18. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA et al (2004). Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13: 159-170. (Pubitemid 38111354)
19. Jeong YH, Park CH, Yoo J, Shin KY, Ahn SM, Kim HS et al (2006). Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 trans-genic mice, an Alzheimer's disease model. FASEBJ20: 729-731. (Pubitemid 46671196)
20. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94: 1550-1555.
21. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH et al (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736. (Pubitemid 17054046)
22. Kim JJ, Fanselow MS (1992). Modality-specific retrograde amnesia of fear. Science 256: 675-677.
23. Kitazawa M, Oddo S, Yamasaki TR, Green KN, La Ferla FM (2005). Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25: 8843-8853. (Pubitemid 41384452)
24. Knobloch M, Farinelli M, Konietzko U, Nitsch RM, Mansuy IM (2007). Abeta oligomer-mediated long-term potentiation im-pairment involves protein phosphatase 1-dependent mechan-isms. J Neurosci 27: 7648-7653. (Pubitemid 47093800)
25. Knobloch M, Mansuy IM (2008). Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 37: 73-82.
26. Koo EH, Squazzo SL (1994). Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269: 17386-17389. (Pubitemid 24218009)
27. Kusakawa G, Saito T, Onuki R, Ishiguto K, Kishimoto T, Hisanaga S (2000). Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275: 17166-17172. (Pubitemid 30398964)
28. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360-364. (Pubitemid 30337070)
29. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X et al (2003). Enhanced proteolysis of betaamyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093. (Pubitemid 38032786)
30. Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009). Soluble oligomers of amyloid ß protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62: 788-801.
31. Lu L, Bao G, Chen H, Xia P, Fan X, Zhang J et al (2003). Modification of hippocampal neurogenesis and neuroplasticity by social environments. Exp Neurol 183: 600-609. (Pubitemid 37205102)
32. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L et al (1999). Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155: 853-862. (Pubitemid 29426831)
33. Mammen AL, Kameyama K, Roche WK, Huganir RL (1997). Phosphorylation of the α-amino-3-hydroxy-5-methylisoxazole 4-propionic acid receptor Glu R1 subunit by calcium/calmodulin-dependent kinase II. J Biol Chem 272: 32528-32533. (Pubitemid 28011939)
34. Mc Lean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al (1999). Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866.
35. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 10: 816-825. (Pubitemid 26114738)
36. Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J et al (2003). Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38: 555-565. (Pubitemid 36645031)
37. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH (1998). p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem 273: 24057-24064. (Pubitemid 28435748)
38. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622. (Pubitemid 129516324)
39. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ et al (1999). Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 274: 18851-18856.
40. Phillips RG, Le Doux JE (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274-285.
41. Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M et al (2009). Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 66: 384-392.
42. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM et al (1992). Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258: 126-129.
43. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY et al (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8: 1051-1058. (Pubitemid 41061516)
44. Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA (2009). Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in /í-Amyloid rat model of Alzheimer's disease. Biol Psychiatry 65: 918-926.
45. Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O (2004). Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann Neurol 55: 801-814. (Pubitemid 38702575)
46. Tsai LH, Delalle I, Caviness Jr VS, Chae T, Harlow E (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371: 419-423. (Pubitemid 24302556)
47. Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL et al (2007). Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry 64: 234-240. (Pubitemid 46220781)
48. Zhang Y, Kurup P, Xu J, Carty N, Fernandez SM, Nygaard HB et al (2010). Genetic reduction of striatal-enriched tyrosine phospha-tase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci USA 107: 19014-19019.
49. Zhao CT, Li K, Li JT, Zheng W, Liang XJ, Geng AQ et al (2009). PKCdelta regulates cortical radial migration by stabilizing the Cdk5 activator p35. Proc Natl Acad Sci USA 106: 21353-21358.
50. Zhao WQ, Santini F, Breese R, Ross D, Zhang XD, Stone DJ et al (2010). Inhibition of calcineurin-mediated endocytosis and α-Amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid ß oligomer-induced synaptic disrup-tion. J Biol Chem 285: 7619-7632.